← back to search

Haidi Xu

Sichuan University · CN
Area of research
Oncology · Materials Chemistry
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Catalytic Processes in Materials Science, Esophageal Cancer Research and Treatment, and Hepatocellular Carcinoma Treatment and Prognosis.
h-index
3
citations
48
works
7
NIH funding
primary concept
email

Recent publications

Immune-related adverse events and their effects on survival outcomes in patients with non-small cell lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis
Frontiers in Oncology 2024cited by 15position: middledoi
Comparison of neoadjuvant immunotherapy versus routine neoadjuvant therapy for patients with locally advanced esophageal cancer: A systematic review and meta-analysis
Frontiers in Immunology 2023cited by 24position: middledoi
Comparison of McKeown Minimally Invasive Esophagectomy vs sweet esophagectomy for esophageal squamous cell carcinoma: A retrospective study
Frontiers in Oncology 2022cited by 9position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yao-Zhong Zhang · The University of Queensland3 papers (2022–2024)Lei Wang · Yuncheng University2 papers (2022–2023)Yuxiang Liang · Zhejiang A & F University2 papers (2023–2024)Fan Yu · United States Naval Academy2 papers (2022–2023)Futao Liu · Peking University2 papers (2023–2024)Chenxi Lin · Hebei Medical University2 papers (2022–2023)Kuankuan Li · Fourth Hospital of Hebei Medical University2 papers (2022–2023)Lei Wang · University of Electronic Science and Technology of China1 papers (2024–2024)Lei Li · Beijing Academy of Artificial Intelligence1 papers (2023–2023)Lei Li · Hebei Medical University1 papers (2022–2022)Na Wang · Hebei Medical University1 papers (2022–2022)Na Wang · Affiliated Hospital of North Sichuan Medical College1 papers (2024–2024)Yuan Mi · Hebei Medical University1 papers (2023–2023)Ziqiang Tian · Hebei Medical University1 papers (2023–2023)Hao Qin · China Pharmaceutical University1 papers (2023–2023)Lei Li · Binzhou University1 papers (2024–2024)Chenxi Lin · ASML (United States)1 papers (2024–2024)Jingge Gheng · Hebei Medical University1 papers (2022–2022)